These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20220721)

  • 1. Agomelatine in the treatment of mood and anxiety disorders.
    Baldwin DS; Lopes AT
    Br J Hosp Med (Lond); 2010 Mar; 71(3):153-6. PubMed ID: 20220721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus on agomelatine.
    Green B
    Curr Med Res Opin; 2011 Apr; 27(4):745-9. PubMed ID: 21271795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agomelatine].
    Tessmer M
    Med Monatsschr Pharm; 2009 Aug; 32(8):282-8. PubMed ID: 19777735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agomelatine-induced hepatotoxicity.
    Štuhec M
    Wien Klin Wochenschr; 2013 Apr; 125(7-8):225-6. PubMed ID: 23519541
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
    Kasper S; Hamon M
    World J Biol Psychiatry; 2009; 10(2):117-26. PubMed ID: 19255935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy.
    De Berardis D; Serroni N; Campanella D; Olivieri L; Moschetta FS; Conti CM; Conti P; Di Giannantonio M
    J Clin Psychopharmacol; 2012 Apr; 32(2):289-90. PubMed ID: 22388158
    [No Abstract]   [Full Text] [Related]  

  • 7. Agomelatine: a preliminary review of a new antidepressant.
    Zupancic M; Guilleminault C
    CNS Drugs; 2006; 20(12):981-92. PubMed ID: 17140278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DSM-IV-based Generalized Anxiety Disorder Severity Scale: preliminary validation using data from a trial of agomelatine versus placebo.
    Stein DJ; Fincham D; Seedat S; de Bodinat C; Ahokas A
    J Nerv Ment Dis; 2009 Jun; 197(6):391-4. PubMed ID: 19525737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agomelatine: a novel atypical antidepressant.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 Dec; 45(12):13-7. PubMed ID: 18246859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agomelatine in the treatment of social anxiety disorder.
    Crippa JA; Hallak JE; Zuardi AW; Chagas MH; Quevedo J; Nardi AE
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1357-8. PubMed ID: 20637821
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.
    Stein DJ; Ahokas AA; de Bodinat C
    J Clin Psychopharmacol; 2008 Oct; 28(5):561-6. PubMed ID: 18794654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agomelatine: an agent against anhedonia and abulia?
    Thome J; Foley P
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S3-7. PubMed ID: 24311062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Agomelatine: the first "melatoninergic" antidepressant].
    Bánki MC
    Neuropsychopharmacol Hung; 2006 Oct; 8(3):105-12. PubMed ID: 17211046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness.
    Kennedy SH; Rizvi SJ
    CNS Drugs; 2010 Jun; 24(6):479-99. PubMed ID: 20192279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of melatonin in mood disorders and the antidepressant effects of agomelatine.
    Srinivasan V; De Berardis D; Shillcutt SD; Brzezinski A
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1503-22. PubMed ID: 22876742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could agomelatine be the ideal antidepressant?
    Pandi-Perumal SR; Srinivasan V; Cardinali DP; Monti MJ
    Expert Rev Neurother; 2006 Nov; 6(11):1595-608. PubMed ID: 17144776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agomelatine in treating generalized anxiety disorder.
    Demyttenaere K
    Expert Opin Investig Drugs; 2014 Jun; 23(6):857-64. PubMed ID: 24766542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agomelatine: a novel pharmacological approach to treating depression.
    Owen RT
    Drugs Today (Barc); 2009 Aug; 45(8):599-608. PubMed ID: 19927226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.
    Buoli M; Mauri MC; Altamura AC
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):885-92. PubMed ID: 24717138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of antidepressants in clinical practice: focus on agomelatine.
    McAllister-Williams RH; Baldwin DS; Haddad PM; Bazire S
    Hum Psychopharmacol; 2010 Mar; 25(2):95-102. PubMed ID: 20196187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.